TP Therapeutics
Clinical-stage structure-based drug design company for the discovery and development of precision medicines for cancer and other diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
€3.7b (Public information from Jun 2022)
Share price
$76.01 TPTX
San Diego California (HQ)
Authorizing premium user...